Vivanza Biosciences Balance Sheet Annual

BSE: 530057 | NSE: - | ISIN: INE984E01035 | Sector: Biotechnology & Drugs

2.08 -0.04 (-1.89%)Updated : 08 Jul 2025

Interim Data

Annual Data

Fiscal Period	2025	2024	2023	2022
Period End Date	Mar 25	Mar 24	Mar 23	Mar 22
Total Liabilities Shareholders' Equity	16.45	19.50	22.48	15.56
Cash Equivalents	0.12	0.17	0.14	0.06
Other Liabilities Total	0.00	0.00	0.00	-
Long Term Debt	3.33	2.68	1.43	2.60
Common Stock Total	4.00	4.00	4.00	4.00
Other Current Assets Total	0.30	0.41	0.33	0.20
Total Assets	16.45	19.50	22.48	15.56
Current Portof LT Debt/ Capital Leases	5.32	2.21	3.28	0.18
Total Equity	3.96	4.64	4.09	3.49
Long Term Investments	0.60	0.60	0.60	0.60
Retained Earnings( Accumulated Deficit)	-0.04	0.64	0.09	-0.51
Total Common Shares Outstanding	4.00	4.00	4.00	4.00
Tangible Book Valueper Share Common Eq	0.58	0.75	0.61	0.46
Total Liabilities	12.49	14.86	18.39	12.07
Total Debt	8.65	5.17	8.00	5.51
Cashand Short Term Investments	0.12	0.17	0.14	0.06
Total Receivables Net	9.70	13.16	16.61	9.77
Deferred Income Tax	0.00	-	0.00	0.00
Accounts Receivable- Trade Net	8.06	11.54	12.48	7.84
Property/ Plant/ Equipment Total- Net	0.70	0.70	0.68	0.68
Total Current Liabilities	9.15	12.18	16.95	9.47
Total Inventory	2.26	2.01	2.47	2.43
Accounts Payable	2.62	8.23	9.55	5.48
Other Currentliabilities Total	1.22	1.46	0.84	1.08
Total Long Term Debt	3.33	2.68	1.43	2.60
Intangibles Net	1.64	0.03	0.03	0.03
Other Long Term Assets Total	0.00	0.00	0.00	0.00
Note Receivable- Long Term	1.14	0.82	0.01	0.20
period Length	0.00	0.00	0.00	0.00
Total Current Assets	12.38	15.74	19.55	12.45
Goodwill Net	-	1.61	1.61	1.61
Notes Payable/ Short Term Debt	-	0.28	3.29	2.74